Here’s Why You Should Buy Zomedica Corp. (ZOM) Now
The Zomedica Corp.’s (ZOM) TRUFORMA platform has made its first sale. With this, Zomedica launched the commercialization of its core product. After reaching a high of $2.72, ZOM’s stock dropped as low as $2.09 before closing the latest session at $2.26. The performance of ZOM stock is 880.05% over the past year, and we have […]